Status: current, Defined. Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5025522016 | Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
| 5025523014 | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | en | Synonym | Active | Case sensitive | SNOMED CT core |
| 5025524015 | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | en | Synonym | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Is a | Human papillomavirus antigen only vaccine product | true | Inferred relationship | Some | ||
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Plays role | Active immunity stimulant role | true | Inferred relationship | Some | ||
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus type 16 antigen | true | Inferred relationship | Some | 1 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus type 18 antigen | true | Inferred relationship | Some | 2 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus type 11 antigen | true | Inferred relationship | Some | 3 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus type 31 antigen | true | Inferred relationship | Some | 4 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus type 33 antigen | true | Inferred relationship | Some | 5 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus type 45 antigen | true | Inferred relationship | Some | 6 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus type 6 antigen | true | Inferred relationship | Some | 7 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus 52 antigen | true | Inferred relationship | Some | 8 | |
| Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Has active ingredient | Human papillomavirus 58 antigen | true | Inferred relationship | Some | 9 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | Direct substance | True | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens only vaccine product | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR